Trends in Medicaid spending on inhalers in the United States, 2012-2018

BACKGROUND: Chronic obstructive pulmonary disease (COPD) and asthma are common respiratory diseases that impose a significant economic burden on Medicaid. Inhalers are the mainstay treatment for relieving symptoms and improving outcomes for COPD and asthma patients. OBJECTIVE: To describe the total...

Descripción completa

Detalles Bibliográficos
Autores principales: Sistani, Farideh, Reed, Robert M, Shah, Chintal H, Zafari, Zafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391144/
https://www.ncbi.nlm.nih.gov/pubmed/34818085
http://dx.doi.org/10.18553/jmcp.2021.27.12.1744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391144/
https://www.ncbi.nlm.nih.gov/pubmed/34818085
http://dx.doi.org/10.18553/jmcp.2021.27.12.1744

Ejemplares similares